Achillion Pharmaceuticals Achillion Today Achillion People Achillion Science
   
About Us
Target Markets
Product Pipeline
News Center
Shareholder Services
Calendar of Events
Press Resources
Investors
Contact Us
Site Map
Press Releases

Shareholder Tools
All Releases
View Summary Achillion Announces Additional Positive Top-Line Phase 2 Data for Elvucitabine
Jun 9, 2008
PDF 11.9 KB Add to Briefcase
View Summary Achillion Nominates ACH-1625 as Lead Candidate in Proprietary Program Targeting HCV Protease
Jun 4, 2008
PDF 10.8 KB Add to Briefcase
View Summary Achillion to Present At Needham Biotechnology Conference
May 23, 2008
PDF 8.9 KB Add to Briefcase
View Summary Achillion Reports First Quarter 2008 Financial Results
May 7, 2008
PDF 13.8 KB Add to Briefcase
View Summary Achillion and FOB Synthesis Announce Collaboration for the Development of Carbapenem Compounds
Apr 8, 2008
PDF 11.1 KB Add to Briefcase
View Summary Achillion Appoints Gary E. Frashier to Board of Directors
Apr 2, 2008
PDF 10.5 KB Add to Briefcase
View Summary Achillion to Present At Cowen Healthcare Conference
Mar 14, 2008
PDF 8.9 KB Add to Briefcase
View Summary Achillion Reports 2007 Fourth Quarter and Year-End Financial Results
Feb 27, 2008
PDF 16.6 KB Add to Briefcase
View Summary Achillion to Present At the BIO CEO and Investor Conference
Feb 8, 2008
PDF 9.4 KB Add to Briefcase
View Summary New Data for Achillion's Elvucitabine Demonstrate Drug's Safety, Efficacy and Suitability for Combination Therapy in HIV-Infected Patients
Jan 31, 2008
PDF 15.4 KB Add to Briefcase
View Summary Achillion Announces Appointment of New Chief Medical Officer
Nov 26, 2007
PDF 10.4 KB Add to Briefcase
View Summary Achillion to Present At Upcoming Conferences
Nov 2, 2007
PDF 9.1 KB Add to Briefcase
View Summary Achillion Reports Third Quarter 2007 Financial Results
Nov 2, 2007
PDF 13.6 KB Add to Briefcase
View Summary Achillion Reports Safety and Potent Antiviral Activity in Topline Results From Elvucitabine Phase 2 Study in HIV-Infected Patients
Oct 15, 2007
PDF 12.1 KB Add to Briefcase
View Summary Achillion to Present At the First Annual Maxim Group Growth Conference
Sep 17, 2007
PDF 8.8 KB Add to Briefcase
View Summary Achillion Appoints Pharmathene CEO David P. Wright to Board of Directors
Aug 22, 2007
PDF 10.1 KB Add to Briefcase
View Summary Achillion Reports 2007 Second Quarter Financial Results
Aug 8, 2007
PDF 15.1 KB Add to Briefcase
View Summary Achillion to Host Second Quarter Investor Conference Call On August 8, 2007
Jul 27, 2007
PDF 8.3 KB Add to Briefcase
View Summary Achillion Announces the Promotion of Milind S. Deshpande, Ph.D. to Executive Vice President of Research
Jun 11, 2007
PDF 10.0 KB Add to Briefcase
View Summary Achillion Announces the Resignation of John C. Pottage, Jr., M.D., Senior Vice President and Chief Medical Officer
May 17, 2007
PDF 10.0 KB Add to Briefcase
Showing 1-20 of 41 Page: 1 2 3  Next 20
= add release to Briefcase
Print Page
Email This
  Home  |  About Us  |  Target Markets  |  Product Pipeline  |  News Center  |  Investors  |  Contact Us  |  Site Map
  © Copyright 2007 Achillion Pharmaceuticals, Inc. All rights reserved.    Terms of Use    Last Updated (June 13, 2007)